Terms: = Breast cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3
394 results:
1. The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant HER2-positive breast cancer.
Park M; Jung E; Park JM; Park S; Ko D; Seo J; Kim S; Nam KD; Kang YK; Farrand L; Hoang VH; Nguyen CT; La MT; Nam G; Park HJ; Ann J; Lee J; Kim YJ; Kim JY; Seo JH
Theranostics; 2024; 14(6):2442-2463. PubMed ID: 38646654
[No Abstract] [Full Text] [Related]
2. Hinokitiol Inhibits breast cancer Cells In Vitro Stemness-Progression and Self-Renewal with Apoptosis and Autophagy Modulation via the CD44/Nanog/SOX2/oct4 Pathway.
Chiang YF; Huang KC; Chen HY; Hamdy NM; Huang TC; Chang HY; Shieh TM; Huang YJ; Hsia SM
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612715
[TBL] [Abstract] [Full Text] [Related]
3. Changes in lymph node surgery in breast cancer and preoperative drug prescription analysis for postoperative pain management: A retrospective, cross-sectional study.
Kang ES; Lim YC; Jang BH; Lee YJ; Ha IH; Lee YS
PLoS One; 2024; 19(4):e0298270. PubMed ID: 38574043
[TBL] [Abstract] [Full Text] [Related]
4. Global Interactome Mapping Reveals Pro-tumorigenic Interactions of NF-κB in breast cancer.
Lapcik P; Stacey RG; Potesil D; Kulhanek P; Foster LJ; Bouchal P
Mol Cell Proteomics; 2024 Apr; 23(4):100744. PubMed ID: 38417630
[TBL] [Abstract] [Full Text] [Related]
5. Are embryonic stem cell markers and ALDH1A1 relevant in the context of breast cancer estrogen positivity?
Mousa NA; Hussein A; Elemam NM; Mohammed G; Elwany M; Basha T; AlHammadi AA; Majzob RS; Talaat IM
Cancer Med; 2024 Feb; 13(3):e7004. PubMed ID: 38400679
[TBL] [Abstract] [Full Text] [Related]
6. The prognostic value of stem cell markers in triple-negative breast cancer.
Almási S; Nagy Á; Krenács T; Lantos T; Zombori T; Cserni G
Pathol Oncol Res; 2023; 29():1611365. PubMed ID: 38188613
[TBL] [Abstract] [Full Text] [Related]
7. Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features.
Leiva MC; Gustafsson A; Garre E; Ståhlberg A; Kovács A; Helou K; Landberg G
J Transl Med; 2023 Dec; 21(1):924. PubMed ID: 38124067
[TBL] [Abstract] [Full Text] [Related]
8. TET1 regulates stem cell properties and cell cycle of cancer stem cells in triple-negative breast cancer via DNA demethylation.
Ghazimoradi MH; Pakravan K; Khalafizadeh A; Babashah S
Biochem Pharmacol; 2024 Jan; 219():115913. PubMed ID: 37995981
[TBL] [Abstract] [Full Text] [Related]
9. Mechanisms of breast cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1.
Semenza GL
Stem Cells Transl Med; 2023 Dec; 12(12):783-790. PubMed ID: 37768037
[TBL] [Abstract] [Full Text] [Related]
10. Mesenchymal Stem Cell-Derived Extracellular Vesicles Increase Human MCF7 breast cancer Cell Proliferation associated with oct4 Expression and ALDH Activity.
Zakiyah N; Wanandi SI; Antarianto RD; Syahrani RA; Arumsari S
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2781-2789. PubMed ID: 37642065
[TBL] [Abstract] [Full Text] [Related]
11. Biological evaluation of [4-(4-aminophenyl)-1-(4-fluorophenyl)-1H-pyrrol-3-yl](3,4,5-trimethoxyphenyl)methanone as potential antineoplastic agent in 2D and 3D breast cancer models.
Mazzoccoli C; Crispo F; Laurenzana I; Pietrafesa M; Sisinni L; Lerose R; Telesca D; Milella MR; Liu T; Della Sala G; Sebastiani J; Silvestri R; La Regina G
Arch Pharm (Weinheim); 2023 Oct; 356(10):e2300354. PubMed ID: 37603378
[TBL] [Abstract] [Full Text] [Related]
12. Estrogen-Related Receptor Alpha (ERRα) Promotes cancer Stem Cell-Like Characteristics in breast cancer.
Muduli K; Prusty M; Pradhan J; Samal AP; Sahu B; Roy DS; Reddy KS; Elangovan S
Stem Cell Rev Rep; 2023 Nov; 19(8):2807-2819. PubMed ID: 37584854
[TBL] [Abstract] [Full Text] [Related]
13. Circular RNA_0000326 accelerates breast cancer development via modulation of the miR-9-3p/YAP1 axis.
Xue XL; Zhao S; Xu MC; Li Y; Liu WF; Qin HZ
Neoplasma; 2023 Jun; 70(3):430-442. PubMed ID: 37498061
[TBL] [Abstract] [Full Text] [Related]
14. Dysregulated Stem Cell Markers Musashi-1 and Musashi-2 are Associated with Therapy Resistance in Inflammatory breast cancer.
Haiduk TS; Sicking M; Brücksken KA; Espinoza-Sánchez NA; Eder KM; Kemper B; Eich HT; Götte M; Greve B; Troschel FM
Arch Med Res; 2023 Sep; 54(6):102855. PubMed ID: 37481823
[TBL] [Abstract] [Full Text] [Related]
15. The deformation of cancer cells through narrow micropores holds the potential to regulate genes that impact cancer malignancy.
Choi JS; Lee SH; Park HB; Chun C; Kim Y; Kim KH; Weon BM; Kim DH; Kim HJ; Lee JH
Lab Chip; 2023 Aug; 23(16):3628-3638. PubMed ID: 37448298
[TBL] [Abstract] [Full Text] [Related]
16. MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative breast cancer MDA-MB-231 Cells.
Pratelli G; Carlisi D; Di Liberto D; Notaro A; Giuliano M; D'Anneo A; Lauricella M; Emanuele S; Calvaruso G; De Blasio A
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446326
[TBL] [Abstract] [Full Text] [Related]
17. p53 Affects Zeb1 Interactome of breast cancer Stem Cells.
Parfenyev SE; Shabelnikov SV; Tolkunova EN; Barlev NA; Mittenberg AG
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372954
[TBL] [Abstract] [Full Text] [Related]
18. Senescent mesenchymal stem/stromal cells in pre-metastatic bone marrow of untreated advanced breast cancer patients.
Borzone FR; Giorello MB; Martinez LM; Sanmartin MC; Feldman L; Dimase F; Batagelj E; Yannarelli G; Chasseing NA
Oncol Res; 2023; 31(3):361-374. PubMed ID: 37305388
[TBL] [Abstract] [Full Text] [Related]
19. Upregulation of the oct3/4 Network in Basal breast cancer Is Associated with Its Metastatic Potential and Shows Tissue Dependent Variability.
Rajan RG; Krutilina RI; Ignatova TN; Pavicevich ZS; Dulatova GM; Lane MA; Chatterjee AR; Rooney RJ; Antony M; Hagerty VR; Kukekov NV; Hanafy KA; Vrionis FD
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298091
[TBL] [Abstract] [Full Text] [Related]
20. Quinolyl-Based PGM Metallarectangles: Antiproliferative Activity, DNA and BSA Protein Interactions, and a Molecular Docking Perspective.
Golding TM; Omondi RO; Biswas S; Chakraborty S; Prince S; Smith GS
Chembiochem; 2023 Jul; 24(13):e202300271. PubMed ID: 37191065
[TBL] [Abstract] [Full Text] [Related]
[Next]
